Copyright Reports & Markets. All rights reserved.

Global Nanofiber Materials for Biomedical Market Insights, Forecast to 2025

Buy now

Table of Contents

    Global Nanofiber Materials for Biomedical Market Research Report 2019-2025, by Manufacturers, Regions, Types and Applications

      1 Study Coverage

      • 1.1 Nanofiber Materials for Biomedical Product
      • 1.2 Key Market Segments in This Study
      • 1.3 Key Manufacturers Covered
      • 1.4 Market by Type
        • 1.4.1 Global Nanofiber Materials for Biomedical Market Size Growth Rate by Type
        • 1.4.2 Synthetic polymers
        • 1.4.3 Natural polymers
        • 1.4.4 Ceramic and inorganic
        • 1.4.5 Carbon and graphene
        • 1.4.6 Metallic
      • 1.5 Market by Application
        • 1.5.1 Global Nanofiber Materials for Biomedical Market Size Growth Rate by Application
        • 1.5.2 Research
        • 1.5.3 Pharmaceuticals
        • 1.5.4 Others
      • 1.6 Study Objectives
      • 1.7 Years Considered

      2 Executive Summary

      • 2.1 Global Nanofiber Materials for Biomedical Production
        • 2.1.1 Global Nanofiber Materials for Biomedical Revenue 2014-2025
        • 2.1.2 Global Nanofiber Materials for Biomedical Production 2014-2025
        • 2.1.3 Global Nanofiber Materials for Biomedical Capacity 2014-2025
        • 2.1.4 Global Nanofiber Materials for Biomedical Marketing Pricing and Trends
      • 2.2 Nanofiber Materials for Biomedical Growth Rate (CAGR) 2019-2025
      • 2.3 Analysis of Competitive Landscape
        • 2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        • 2.3.2 Key Nanofiber Materials for Biomedical Manufacturers
      • 2.4 Market Drivers, Trends and Issues
      • 2.5 Macroscopic Indicator
        • 2.5.1 GDP for Major Regions
        • 2.5.2 Price of Raw Materials in Dollars: Evolution

      3 Market Size by Manufacturers

      • 3.1 Nanofiber Materials for Biomedical Production by Manufacturers
        • 3.1.1 Nanofiber Materials for Biomedical Production by Manufacturers
        • 3.1.2 Nanofiber Materials for Biomedical Production Market Share by Manufacturers
      • 3.2 Nanofiber Materials for Biomedical Revenue by Manufacturers
        • 3.2.1 Nanofiber Materials for Biomedical Revenue by Manufacturers (2014-2019)
        • 3.2.2 Nanofiber Materials for Biomedical Revenue Share by Manufacturers (2014-2019)
      • 3.3 Nanofiber Materials for Biomedical Price by Manufacturers
      • 3.4 Mergers & Acquisitions, Expansion Plans

      4 Nanofiber Materials for Biomedical Production by Regions

      • 4.1 Global Nanofiber Materials for Biomedical Production by Regions
        • 4.1.1 Global Nanofiber Materials for Biomedical Production Market Share by Regions
        • 4.1.2 Global Nanofiber Materials for Biomedical Revenue Market Share by Regions
      • 4.2 United States
        • 4.2.1 United States Nanofiber Materials for Biomedical Production
        • 4.2.2 United States Nanofiber Materials for Biomedical Revenue
        • 4.2.3 Key Players in United States
        • 4.2.4 United States Nanofiber Materials for Biomedical Import & Export
      • 4.3 Europe
        • 4.3.1 Europe Nanofiber Materials for Biomedical Production
        • 4.3.2 Europe Nanofiber Materials for Biomedical Revenue
        • 4.3.3 Key Players in Europe
        • 4.3.4 Europe Nanofiber Materials for Biomedical Import & Export
      • 4.4 China
        • 4.4.1 China Nanofiber Materials for Biomedical Production
        • 4.4.2 China Nanofiber Materials for Biomedical Revenue
        • 4.4.3 Key Players in China
        • 4.4.4 China Nanofiber Materials for Biomedical Import & Export
      • 4.5 Japan
        • 4.5.1 Japan Nanofiber Materials for Biomedical Production
        • 4.5.2 Japan Nanofiber Materials for Biomedical Revenue
        • 4.5.3 Key Players in Japan
        • 4.5.4 Japan Nanofiber Materials for Biomedical Import & Export
      • 4.6 Other Regions
        • 4.6.1 South Korea
        • 4.6.2 India
        • 4.6.3 Southeast Asia

      5 Nanofiber Materials for Biomedical Consumption by Regions

      • 5.1 Global Nanofiber Materials for Biomedical Consumption by Regions
        • 5.1.1 Global Nanofiber Materials for Biomedical Consumption by Regions
        • 5.1.2 Global Nanofiber Materials for Biomedical Consumption Market Share by Regions
      • 5.2 North America
        • 5.2.1 North America Nanofiber Materials for Biomedical Consumption by Application
        • 5.2.2 North America Nanofiber Materials for Biomedical Consumption by Countries
        • 5.2.3 United States
        • 5.2.4 Canada
        • 5.2.5 Mexico
      • 5.3 Europe
        • 5.3.1 Europe Nanofiber Materials for Biomedical Consumption by Application
        • 5.3.2 Europe Nanofiber Materials for Biomedical Consumption by Countries
        • 5.3.3 Germany
        • 5.3.4 France
        • 5.3.5 UK
        • 5.3.6 Italy
        • 5.3.7 Russia
      • 5.4 Asia Pacific
        • 5.4.1 Asia Pacific Nanofiber Materials for Biomedical Consumption by Application
        • 5.4.2 Asia Pacific Nanofiber Materials for Biomedical Consumption by Countries
        • 5.4.3 China
        • 5.4.4 Japan
        • 5.4.5 South Korea
        • 5.4.6 India
        • 5.4.7 Australia
        • 5.4.8 Indonesia
        • 5.4.9 Thailand
        • 5.4.10 Malaysia
        • 5.4.11 Philippines
        • 5.4.12 Vietnam
      • 5.5 Central & South America
        • 5.5.1 Central & South America Nanofiber Materials for Biomedical Consumption by Application
        • 5.5.2 Central & South America Nanofiber Materials for Biomedical Consumption by Countries
        • 5.5.3 Brazil
      • 5.6 Middle East and Africa
        • 5.6.1 Middle East and Africa Nanofiber Materials for Biomedical Consumption by Application
        • 5.6.2 Middle East and Africa Nanofiber Materials for Biomedical Consumption by Countries
        • 5.6.3 Turkey
        • 5.6.4 GCC Countries
        • 5.6.5 Egypt
        • 5.6.6 South Africa

      6 Market Size by Type

      • 6.1 Global Nanofiber Materials for Biomedical Breakdown Dada by Type
      • 6.2 Global Nanofiber Materials for Biomedical Revenue by Type
      • 6.3 Nanofiber Materials for Biomedical Price by Type

      7 Market Size by Application

      • 7.1 Overview
      • 7.2 Global Nanofiber Materials for Biomedical Breakdown Dada by Application
        • 7.2.1 Global Nanofiber Materials for Biomedical Consumption by Application
        • 7.2.2 Global Nanofiber Materials for Biomedical Consumption Market Share by Application (2014-2019)

      8 Manufacturers Profiles

      • 8.1 Ahlstrom
        • 8.1.1 Ahlstrom Company Details
        • 8.1.2 Company Description
        • 8.1.3 Capacity, Production and Value of Nanofiber Materials for Biomedical
        • 8.1.4 Nanofiber Materials for Biomedical Product Description
        • 8.1.5 SWOT Analysis
      • 8.2 Asahi Kasei
        • 8.2.1 Asahi Kasei Company Details
        • 8.2.2 Company Description
        • 8.2.3 Capacity, Production and Value of Nanofiber Materials for Biomedical
        • 8.2.4 Nanofiber Materials for Biomedical Product Description
        • 8.2.5 SWOT Analysis
      • 8.3 Donaldson
        • 8.3.1 Donaldson Company Details
        • 8.3.2 Company Description
        • 8.3.3 Capacity, Production and Value of Nanofiber Materials for Biomedical
        • 8.3.4 Nanofiber Materials for Biomedical Product Description
        • 8.3.5 SWOT Analysis
      • 8.4 Nanofiber Solutions
        • 8.4.1 Nanofiber Solutions Company Details
        • 8.4.2 Company Description
        • 8.4.3 Capacity, Production and Value of Nanofiber Materials for Biomedical
        • 8.4.4 Nanofiber Materials for Biomedical Product Description
        • 8.4.5 SWOT Analysis
      • 8.5 SNS Nanofiber Technology
        • 8.5.1 SNS Nanofiber Technology Company Details
        • 8.5.2 Company Description
        • 8.5.3 Capacity, Production and Value of Nanofiber Materials for Biomedical
        • 8.5.4 Nanofiber Materials for Biomedical Product Description
        • 8.5.5 SWOT Analysis
      • 8.6 TEIJIN
        • 8.6.1 TEIJIN Company Details
        • 8.6.2 Company Description
        • 8.6.3 Capacity, Production and Value of Nanofiber Materials for Biomedical
        • 8.6.4 Nanofiber Materials for Biomedical Product Description
        • 8.6.5 SWOT Analysis
      • 8.7 Toray
        • 8.7.1 Toray Company Details
        • 8.7.2 Company Description
        • 8.7.3 Capacity, Production and Value of Nanofiber Materials for Biomedical
        • 8.7.4 Nanofiber Materials for Biomedical Product Description
        • 8.7.5 SWOT Analysis
      • 8.8 3-D Matrix Medical Technology
        • 8.8.1 3-D Matrix Medical Technology Company Details
        • 8.8.2 Company Description
        • 8.8.3 Capacity, Production and Value of Nanofiber Materials for Biomedical
        • 8.8.4 Nanofiber Materials for Biomedical Product Description
        • 8.8.5 SWOT Analysis
      • 8.9 AMSilk
        • 8.9.1 AMSilk Company Details
        • 8.9.2 Company Description
        • 8.9.3 Capacity, Production and Value of Nanofiber Materials for Biomedical
        • 8.9.4 Nanofiber Materials for Biomedical Product Description
        • 8.9.5 SWOT Analysis
      • 8.10 Argonide
        • 8.10.1 Argonide Company Details
        • 8.10.2 Company Description
        • 8.10.3 Capacity, Production and Value of Nanofiber Materials for Biomedical
        • 8.10.4 Nanofiber Materials for Biomedical Product Description
        • 8.10.5 SWOT Analysis
      • 8.11 Collagen Matrix

      9 Production Forecasts

      • 9.1 Nanofiber Materials for Biomedical Production and Revenue Forecast
        • 9.1.1 Global Nanofiber Materials for Biomedical Production Forecast 2019-2025
        • 9.1.2 Global Nanofiber Materials for Biomedical Revenue Forecast 2019-2025
      • 9.2 Nanofiber Materials for Biomedical Production and Revenue Forecast by Regions
        • 9.2.1 Global Nanofiber Materials for Biomedical Revenue Forecast by Regions
        • 9.2.2 Global Nanofiber Materials for Biomedical Production Forecast by Regions
      • 9.3 Nanofiber Materials for Biomedical Key Producers Forecast
        • 9.3.1 United States
        • 9.3.2 Europe
        • 9.3.3 China
        • 9.3.4 Japan
      • 9.4 Forecast by Type
        • 9.4.1 Global Nanofiber Materials for Biomedical Production Forecast by Type
        • 9.4.2 Global Nanofiber Materials for Biomedical Revenue Forecast by Type

      10 Consumption Forecast

      • 10.1 Consumption Forecast by Application
      • 10.2 Nanofiber Materials for Biomedical Consumption Forecast by Regions
      • 10.3 North America Market Consumption Forecast
        • 10.3.1 North America Nanofiber Materials for Biomedical Consumption Forecast by Countries 2019-2025
        • 10.3.2 United States
        • 10.3.3 Canada
        • 10.3.4 Mexico
      • 10.4 Europe Market Consumption Forecast
        • 10.4.1 Europe Nanofiber Materials for Biomedical Consumption Forecast by Countries 2019-2025
        • 10.4.2 Germany
        • 10.4.3 France
        • 10.4.4 UK
        • 10.4.5 Italy
        • 10.4.6 Russia
      • 10.5 Asia Pacific Market Consumption Forecast
        • 10.5.1 Asia Pacific Nanofiber Materials for Biomedical Consumption Forecast by Countries 2019-2025
        • 10.5.2 China
        • 10.5.3 Japan
        • 10.5.4 Korea
        • 10.5.5 India
        • 10.5.6 Australia
        • 10.5.7 Indonesia
        • 10.5.8 Thailand
        • 10.5.9 Malaysia
        • 10.5.10 Philippines
        • 10.5.11 Vietnam
      • 10.6 Central & South America Market Consumption Forecast
        • 10.6.1 Central & South America Nanofiber Materials for Biomedical Consumption Forecast by Country 2019-2025
        • 10.6.2 Brazil
      • 10.7 Middle East and Africa Market Consumption Forecast
        • 10.7.1 Middle East and Africa Nanofiber Materials for Biomedical Consumption Forecast by Countries 2019-2025
        • 10.7.2 Middle East and Africa
        • 10.7.3 Turkey
        • 10.7.4 GCC Countries
        • 10.7.5 Egypt
        • 10.7.6 South Africa

      11 Upstream, Industry Chain and Downstream Customers Analysis

      • 11.1 Analysis of Nanofiber Materials for Biomedical Upstream Market
        • 11.1.1 Nanofiber Materials for Biomedical Key Raw Material
        • 11.1.2 Typical Suppliers of Key Nanofiber Materials for Biomedical Raw Material
        • 11.1.3 Nanofiber Materials for Biomedical Raw Material Market Concentration Rate
      • 11.2 Nanofiber Materials for Biomedical Industry Chain Analysis
      • 11.3 Marketing & Distribution
      • 11.4 Nanofiber Materials for Biomedical Distributors
      • 11.5 Nanofiber Materials for Biomedical Customers

      12 Opportunities & Challenges, Threat and Affecting Factors

      • 12.1 Market Opportunities
      • 12.2 Market Challenges
      • 12.3 Porter's Five Forces Analysis

      13 Key Findings

        14 Appendix

        • 14.1 Research Methodology
          • 14.1.1 Methodology/Research Approach
          • 14.1.2 Data Source
        • 14.2 Author Details

        Nanomaterials, along with advancements in nanotechnology, have the potential to revolutionize existing industries and create entirely new applications. In the last decade, nanotechnology has advanced at a rapid pace, and it holds enormous prospects for biomedical applications. Nanofibers are important and versatile class of one-dimensional nanomaterials that are attracting increasing attention from academics as well as several industries in recent years. Nanofibers can be prepared from a wide range of materials such as polymers, ceramics, and metals.
        Nanofibers are proving to be an important material for applications in biomedical industry including medical filters and membranes, medical textiles, wound dressings, drug delivery, tissue engineering, and biosensors.
        The need for implants with enhanced functional life and biodegradability as one of the primary growth factors for this market. The traditional implant materials have short functional life, with failures arising from implant loosening, inflammation, infection, and wear debris. This resulted in the need for the development of new cytocompatible bone substitutes with substantially enhanced functional life to regenerate bone tissues. Titanium and its alloys are widely used in orthopedic and dental implant materials due to their compatible mechanical properties and biocompatibility.
        Global Nanofiber Materials for Biomedical market size will increase to xx Million US$ by 2025, from xx Million US$ in 2018, at a CAGR of xx% during the forecast period. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Nanofiber Materials for Biomedical.

        This report researches the worldwide Nanofiber Materials for Biomedical market size (value, capacity, production and consumption) in key regions like United States, Europe, Asia Pacific (China, Japan) and other regions.
        This study categorizes the global Nanofiber Materials for Biomedical breakdown data by manufacturers, region, type and application, also analyzes the market status, market share, growth rate, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.

        The following manufacturers are covered in this report:
        Ahlstrom
        Asahi Kasei
        Donaldson
        Nanofiber Solutions
        SNS Nanofiber Technology
        TEIJIN
        Toray
        3-D Matrix Medical Technology
        AMSilk
        Argonide
        Collagen Matrix

        Nanofiber Materials for Biomedical Breakdown Data by Type
        Synthetic polymers
        Natural polymers
        Ceramic and inorganic
        Carbon and graphene
        Metallic
        Nanofiber Materials for Biomedical Breakdown Data by Application
        Research
        Pharmaceuticals
        Others

        Nanofiber Materials for Biomedical Production Breakdown Data by Region
        United States
        Europe
        China
        Japan
        Other Regions

        Nanofiber Materials for Biomedical Consumption Breakdown Data by Region
        North America
        United States
        Canada
        Mexico
        Asia-Pacific
        China
        India
        Japan
        South Korea
        Australia
        Indonesia
        Malaysia
        Philippines
        Thailand
        Vietnam
        Europe
        Germany
        France
        UK
        Italy
        Russia
        Rest of Europe
        Central & South America
        Brazil
        Rest of South America
        Middle East & Africa
        GCC Countries
        Turkey
        Egypt
        South Africa
        Rest of Middle East & Africa

        The study objectives are:
        To analyze and research the global Nanofiber Materials for Biomedical capacity, production, value, consumption, status and forecast;
        To focus on the key Nanofiber Materials for Biomedical manufacturers and study the capacity, production, value, market share and development plans in next few years.
        To focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
        To define, describe and forecast the market by type, application and region.
        To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
        To identify significant trends and factors driving or inhibiting the market growth.
        To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
        To strategically analyze each submarket with respect to individual growth trend and their contribution to the market.
        To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
        To strategically profile the key players and comprehensively analyze their growth strategies.

        In this study, the years considered to estimate the market size of Nanofiber Materials for Biomedical :
        History Year: 2014-2018
        Base Year: 2018
        Estimated Year: 2019
        Forecast Year 2019 to 2025
        For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

        Buy now